@prefix np: . @prefix npx: . @prefix ns1: . @prefix ns2: . @prefix ns3: . @prefix orcid: . @prefix prov: . @prefix rdf: . @prefix rdfs: . @prefix sub: . @prefix this: . @prefix xsd: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { ns1:show . } sub:provenance { sub:_assertion prov:wasGeneratedBy "S&T TWOC Project - version 4", "S&T TWOC version 3" . sub:_version prov:value "2"^^xsd:integer . sub:assertion prov:generatedAtTime "2023-07-20T09:32:28.087390"^^xsd:dateTime . rdf:OBJECT rdfs:label "encouraging data" . rdf:OBJECT-POSITION rdfs:label "(18, 29)" . rdf:PREDICATE rdfs:label "showed" . rdf:PREDICATE-POSITION rdfs:label "30" . rdf:SUBJECT rdfs:label "Dexamethasone and tocilizumab" . rdf:SUBJECT-POSITION rdfs:label "(18, 29)" . rdf:Statement rdfs:label "Dexamethasone and tocilizumab showed encouraging data, but Dexamethasone and tocilizumab's use needs to be further validated." . rdfs:ABSTRACT-UID ns2:50 "fp4chn9a" . rdfs:TRIPLE-UID ns3:fp4chn9a-TRIPLE-ABSTRACT-1 "fp4chn9a-TRIPLE-ABSTRACT-1" . rdfs:label "data" . rdfs:label "tocilizumab" . } sub:pubinfo { sub:sig npx:hasAlgorithm "RSA"; npx:hasPublicKey "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"; npx:hasSignature "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"; npx:hasSignatureTarget this: . this: prov:wasAttributedTo orcid:0000-0003-4692-1377 . }